AI Articles and Analysis about Natural Language Processing

Artificial Intelligence at AstraZeneca-1-min

Artificial Intelligence at AstraZeneca

AstraZeneca is a global biopharmaceutical company that researches, develops, manufactures, and markets prescription drugs and vaccines. Its key therapeutic areas include oncology, cardiovascular, renal, metabolism, respiratory, and immunology. In 2022, the company reported revenue of $42.67 billion and a profit of $4.08 billion. The company has a significant global presence, employing around 89,900 people across more than 60 countries as of 2023.

Leveled Approaches to AI for Asset Management Challenges-1-min

Leveled Approaches to AI for Asset Management Challenges – with Aman Thind of State Street

The asset management industry is going through several challenges, like the prolonged low-interest rate environment, dwindling margins, increased cost pressures, and squeezed profitability. Meanwhile, exponential growth in data volumes has overwhelmed legacy data management systems and analytical tools, making it tiring to process and extract valuable insights from the deluge of information. 

Tracing AI
and NLP’s Journey
to the Mainstream-1-min

Tracing AI and Natural Language Processing’s Journey to the Mainstream – with Matt Berseth of NLP Logix

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Overcoming Cultural and Technological Hurdles for AI Integration in Life Sciences-1-min

Overcoming Cultural and Technological Hurdles for AI Integration in Life Sciences – with Daniel Ferrante of Deloitte

Far beyond surface-level 'chatbot' software, and other customer-facing support systems, the same generative AI (GenAI) capabilities having direct impacts across language workflows in front-office tasks in financial and legal services is also having a direct impact on how research teams in the life sciences space are targeting solutions for rare diseases and novel treatments. 

enAI Use Cases for Insurance, from Marketing to Copilots-1-min

Generative AI Use Cases for Insurance, from Marketing to Copilots – with John Almasan of TIAA

As new generative AI use cases continue to reshape the enterprise landscape across the global economy, many sectors are still weathering significant risks to keep pace with the adoption hype. Deloitte's "State of Generative AI in the Enterprise 2024" report found that 79% of respondents expect generative AI to transform their organizations within three years. However, companies must approach these investments cautiously with a focus on responsible implementation. 

Essentials of Deploying Large Language Models in the Enterprise – v.2-1-min

Essentials of Deploying Large Language Models in the Enterprise – with Anton Kornienko and Ben Webster of NLP Logix

Deploying large language models (LLMs) in an enterprise setting requires management teams to adopt a strategic approach tailor-made for their organizations, which research consistently shows must consider various essential factors. 

Multichannel Customer Journeys in Financial Services-1

Multichannel Customer Journeys in Financial Services – with Anuj Maniar of Deloitte

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

UNICRI on responsible AI criteria and other tool kits@2x-min

UNICRI-Approved Responsible AI Toolkits for Law Enforcement

The United Nations Interregional Crime and Justice Research Institute (UNICRI) was established in 1968 as an autonomous institution in response to a United Nations resolution urging expanded crime prevention and criminal justice activities. UNICRI's mission is to advance justice, crime prevention, security, and the rule of law to support peace, human rights, and sustainable development.